脫髮、稀髮-多學科研證復康方案
- 藥物及其他醫療方案,請遵醫從醫生建議
- 飲食營養請依營養師指引
- 運動及或心理輔導,請參考各專家建議
- 為免錯誤診斷及漏診,請上傳最近一個月醫院的專業診斷報告,如證實是此症,則可參加試用期不如意退款計劃#。
可能適合的補充劑支援:
標準組合:
- 試用時期: 8星期
# <試用期不如意退款計劃>,請參考相關文件
If you have this disease, please follow your doctor's complete medical plan. You must consult the attending doctor before using the multidisciplinary rehabilitation plan. If your attending doctor does not recommend you to join the supplement conditioning combination, please do not use it. If you need to seek second consultation from other doctors, you can contact our online "Doctors Without Borders", or another professional doctor in your own city.
Hair Loss, Thin Hair
Polycystic ovarian syndrome (PCOS) is the commonest endocrine disorder in women having wide range of clinical manifestation. These women may present with reproductive, dermatological, metabolic, psychological, or neoplastic implications from adolescence to menopause. The common dermatological manifestations include hirsutism, acne, alopecia, or acanthosis nigricans. Women presenting with these dermatological manifestations must be evaluated for PCOS. A multidisciplinary team approach involving a reproductive endocrinologist, dermatologist, psychologist/psychiatrist, dietician, and sometimes a bariatric surgeon should be undertaken for long-term management of these patients. Unless metabolic and underlying endocrinal disturbances arecorrected and simultaneous life-style modification is adopted, cosmetic treatment would give only temporary relief.
Multidisciplinary research and rehabilitation program for Hair Loss, Thin Hair
- Please follow the doctor's advice for drugs and other medical plans
- Please follow the guidance of nutritionist
- For sports or psychological counseling, please refer to the experts' suggestions
- In order to avoid misdiagnosis and missed diagnosis, please upload the professional diagnosis report of the hospital in the latest month. If it is confirmed to be this disease, you can participate in the
.#
Possible supplements supporting:
Standard combination:
- Mixed Inositol X4
- Sleeping Study X2
- Trial period: 8 weeks
# Please refer to the relevant documents for the